BACKGROUND: Sinonasal bitter taste receptors (T2Rs) contribute to upper airway innate immunity and correlate with chronic rhinosinusitis (CRS) clinical outcomes. A subset of T2Rs expressed on sinonasal solitary chemosensory cells (SCCs) are activated by denatonium, resulting in a calcium-mediated secretion of bactericidal antimicrobial peptides (AMPs) in neighboring ciliated epithelial cells. We hypothesized that there is patient variability in the amount of bacterial killing induced by different concentrations of denatonium and that the differences correlate with CRS clinical outcomes. METHODS: Bacterial growth inhibition was quantified after mixing bacteria with airway surface liquid (ASL) collected from denatonium-stimulated sinonasal air-liquid interface (ALI) cultures. Patient ASL bacterial killing at 0.1 mM denatonium and baseline characteristics and sinus surgery outcomes were compared between these populations. RESULTS: There is variability in the degree of denatonium-induced bacterial killing between patients. In CRS with nasal polyps (CRSwNP), patients with increased bacterial killing after stimulation with low levels of denatonium undergo significantly more functional endoscopic sinus surgeries (FESSs) (p = 0.037) and have worse 6-month post-FESS 22-item Sino-Nasal Outcome Test (SNOT-22) scores (p = 0.012). CONCLUSION: Bacterial killing after stimulation with low levels of denatonium correlates with number of prior FESS and postoperative SNOT-22 scores in CRSwNP. Some symptoms of CRS in patients with hyperresponsiveness to low levels of denatonium may be due to increased airway immune activity or inherent disease severity.
BACKGROUND: Sinonasal bitter taste receptors (T2Rs) contribute to upper airway innate immunity and correlate with chronic rhinosinusitis (CRS) clinical outcomes. A subset of T2Rs expressed on sinonasal solitary chemosensory cells (SCCs) are activated by denatonium, resulting in a calcium-mediated secretion of bactericidal antimicrobial peptides (AMPs) in neighboring ciliated epithelial cells. We hypothesized that there is patient variability in the amount of bacterial killing induced by different concentrations of denatonium and that the differences correlate with CRS clinical outcomes. METHODS: Bacterial growth inhibition was quantified after mixing bacteria with airway surface liquid (ASL) collected from denatonium-stimulated sinonasal air-liquid interface (ALI) cultures. Patient ASL bacterial killing at 0.1 mM denatonium and baseline characteristics and sinus surgery outcomes were compared between these populations. RESULTS: There is variability in the degree of denatonium-induced bacterial killing between patients. In CRS with nasal polyps (CRSwNP), patients with increased bacterial killing after stimulation with low levels of denatonium undergo significantly more functional endoscopic sinus surgeries (FESSs) (p = 0.037) and have worse 6-month post-FESS 22-item Sino-Nasal Outcome Test (SNOT-22) scores (p = 0.012). CONCLUSION: Bacterial killing after stimulation with low levels of denatonium correlates with number of prior FESS and postoperative SNOT-22 scores in CRSwNP. Some symptoms of CRS in patients with hyperresponsiveness to low levels of denatonium may be due to increased airway immune activity or inherent disease severity.
Authors: Yinyan Lai; Bei Chen; Jianbo Shi; James N Palmer; David W Kennedy; Noam A Cohen Journal: J Allergy Clin Immunol Date: 2011-10-07 Impact factor: 10.793
Authors: Joshua L Kennedy; Matthew A Hubbard; Phillip Huyett; James T Patrie; Larry Borish; Spencer C Payne Journal: Ann Allergy Asthma Immunol Date: 2013-07-30 Impact factor: 6.347
Authors: Jonathan Garneau; Michael Ramirez; Samuel G Armato; William F Sensakovic; Megan K Ford; Colin S Poon; Daniel T Ginat; Adam Starkey; Fuad M Baroody; Jayant M Pinto Journal: Int Forum Allergy Rhinol Date: 2015-04-08 Impact factor: 3.858
Authors: Richard M Rosenfeld; David Andes; Neil Bhattacharyya; Dickson Cheung; Steven Eisenberg; Theodore G Ganiats; Andrea Gelzer; Daniel Hamilos; Richard C Haydon; Patricia A Hudgins; Stacie Jones; Helene J Krouse; Lawrence H Lee; Martin C Mahoney; Bradley F Marple; Col John P Mitchell; Robert Nathan; Richard N Shiffman; Timothy L Smith; David L Witsell Journal: Otolaryngol Head Neck Surg Date: 2007-09 Impact factor: 3.497
Authors: John F Pallanch; Lifeng Yu; David Delone; Rich Robb; David R Holmes; Jon Camp; Phil Edwards; Cynthia H McCollough; Jens Ponikau; Amy C Dearking; John Lane; Andrew Primak; Aaron Shinkle; John Hagan; Evangelo Frigas; Joseph J Ocel; Nicole Tombers; Rizwan Siwani; Nicholas M Orme; Kurtis B Reed; Nivedita Jerath; Robinder Dhillon; Hirohito Kita Journal: Int Forum Allergy Rhinol Date: 2013-09-17 Impact factor: 3.858
Authors: Jonathan H Chen; Christopher I Song; Nanki Hura; Anirudh Saraswathula; Stella M Seal; Andrew P Lane; Nicholas R Rowan Journal: Int Forum Allergy Rhinol Date: 2022-01-05 Impact factor: 5.426
Authors: Alan D Workman; Steven G Brooks; Michael A Kohanski; Mariel T Blasetti; Beverly J Cowart; Corrine Mansfield; David W Kennedy; James N Palmer; Nithin D Adappa; Danielle R Reed; Noam A Cohen Journal: J Allergy Clin Immunol Pract Date: 2017-10-18
Authors: Vasiliki Triantafillou; Alan D Workman; Michael A Kohanski; Noam A Cohen Journal: Front Cell Infect Microbiol Date: 2018-03-07 Impact factor: 5.293
Authors: Cailu Lin; Alyssa M Civantos; Monique Arnold; Elizabeth M Stevens; Beverly J Cowart; Lauren R Colquitt; Corrine Mansfield; David W Kennedy; Steven G Brooks; Alan D Workman; Mariel T Blasetti; Michael A Kohanski; Laurel Doghramji; Jennifer E Douglas; Ivy W Maina; James N Palmer; Nithin D Adappa; Danielle R Reed; Noam A Cohen Journal: Int Forum Allergy Rhinol Date: 2020-08-26 Impact factor: 3.858
Authors: Elizabeth A Sell; Jorge F Ortiz-Carpena; De'Broski R Herbert; Noam A Cohen Journal: Ann Allergy Asthma Immunol Date: 2020-10-26 Impact factor: 6.347
Authors: Alan D Workman; Ivy W Maina; Steven G Brooks; Michael A Kohanski; Beverly J Cowart; Corrine Mansfield; David W Kennedy; James N Palmer; Nithin D Adappa; Danielle R Reed; Robert J Lee; Noam A Cohen Journal: Front Immunol Date: 2018-03-28 Impact factor: 7.561
Authors: Joshua P Earl; Nithin D Adappa; Jaroslaw Krol; Archana S Bhat; Sergey Balashov; Rachel L Ehrlich; James N Palmer; Alan D Workman; Mariel Blasetti; Bhaswati Sen; Jocelyn Hammond; Noam A Cohen; Garth D Ehrlich; Joshua Chang Mell Journal: Microbiome Date: 2018-10-23 Impact factor: 14.650